The DOI matches its Crossref record; 88 of the 88 references it cites were found in a registry or an index.
Marine Natural Products: A New Wave of Drugs?
Open accessAbstract
The largely unexplored marine world that presumably harbors the most biodiversity may be the vastest resource to discover novel 'validated' structures with novel modes of action that cover biologically relevant chemical space. Several challenges, including the supply problem and target identification, need to be met for successful drug development of these often complex molecules; however, approaches are available to overcome the hurdles. Advances in technologies such as sampling strategies, nanoscale NMR for structure determination, total chemical synthesis, fermentation and biotechnology are all crucial to the success of marine natural products as drug leads. We illustrate the high degree of innovation in the field of marine natural products, which in our view will lead to a new wave of drugs that flow into the market and pharmacies in the future.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: A Bacterium That Can Grow by Using Arsenic Instead of Phosphorus
Wolfe-Simon, F., Blum, J. S., Kulp, T. R., Gordon, G. W., Hoeft, S. E., Pett-Ridge, J., Stolz, J. F., Webb, S. M., Weber, P. K., Davies, P. C. W., et al. (2011) · Science · doi:10.1126/science.1197258 · Cited by 503
RetractedNatural products as sources of new drugs over the last 25 years
Newman, D. J., & Cragg, G. M. (2007) · Journal of Natural Products · doi:10.1021/np068054v · Cited by 5,517
Faulkner, D. J. (1990) · Natural Product Reports · doi:10.1039/np9900700269 · Cited by 4,866
Target identification using drug affinity responsive target stability (DARTS)
Lomenick, B., Hao, R., Jonai, N., Chin, R. M., Aghajan, M., Warburton, S., Wang, J., Wu, R. P., Gomez, F., Loo, J. A., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0910040106 · Cited by 1,095
Feling, R. H., Buchanan, G. O., Mincer, T. J., Kauffman, C. A., Jensen, P. R., & Fenical, W. (2003) · Angewandte Chemie International Edition · doi:10.1002/anie.200390115 · Cited by 1,057
The Sorcerer II Global Ocean Sampling Expedition: Expanding the Universe of Protein Families
Yooseph, S., Sutton, G., Rusch, D. B., Halpern, A. L., Williamson, S. J., Remington, K., Eisen, J. A., Heidelberg, K. B., Manning, G., Li, W., et al. (2007) · PLoS Biology · doi:10.1371/journal.pbio.0050016 · Cited by 924
Developing a new resource for drug discovery: marine actinomycete bacteria
Fenical, W., & Jensen, P. R. (2006) · Nature Chemical Biology · doi:10.1038/nchembio841 · Cited by 786
The odyssey of marine pharmaceuticals: a current pipeline perspective
Mayer, A. M. S., Glaser, K. B., Cuevas, C., Jacobs, R. S., Kem, W., Little, R. D., McIntosh, J. M., Newman, D. J., Potts, B. C., & Shuster, D. E. (2010) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2010.02.005 · Cited by 666
Ziconotide: Neuronal Calcium Channel Blocker for Treating Severe Chronic Pain
Miljanich, G. P. (2004) · Current Medicinal Chemistry · doi:10.2174/0929867043363884 · Cited by 607
Marine natural products as anticancer drugs
Simmons, T. L., Andrianasolo, E., McPhail, K., Flatt, P., & Gerwick, W. H. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.333.4.2 · Cited by 597
Cited by
Faulkner, D. J. (1990) · Natural Product Reports · doi:10.1039/np9900700269 · Cited by 4,866
Luteolin, a flavonoid, as an anticancer agent: A review
Imran, M., Rauf, A., Abu-Izneid, T., Nadeem, M., Shariati, M. A., Khan, I. A., Imran, A., Orhan, I. E., Rizwan, M., Atif, M., et al. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.108612 · Cited by 931
Martins, A., Vieira, H., Gaspar, H., & Santos, S. (2014) · Marine Drugs · doi:10.3390/md12021066 · Cited by 572
Blunt, J. W., Copp, B. R., Keyzers, R. A., Munro, M. H. G., & Prinsep, M. R. (2013) · Nat. Prod. Rep. · doi:10.1039/c2np20112g · Cited by 518
Mayer, A., Rodríguez, A., Taglialatela-Scafati, O., & Fusetani, N. (2013) · Marine Drugs · doi:10.3390/md11072510 · Cited by 436
Marine Peptides: Bioactivities and Applications
Cheung, R., Ng, T., & Wong, J. (2015) · Marine Drugs · doi:10.3390/md13074006 · Cited by 391
Shannon, E., & Abu-Ghannam, N. (2016) · Marine Drugs · doi:10.3390/md14040081 · Cited by 385
Karthikeyan, A., Joseph, A., & Nair, B. G. (2022) · Journal of Genetic Engineering and Biotechnology · doi:10.1186/s43141-021-00290-4 · Cited by 336
Strategies to diversify natural products for drug discovery
Li, G., & Lou, H. (2018) · Medicinal Research Reviews · doi:10.1002/med.21474 · Cited by 278
Ruocco, N., Costantini, S., Guariniello, S., & Costantini, M. (2016) · Molecules · doi:10.3390/molecules21050551 · Cited by 267
Lyu, C., Chen, T., Qiang, B., Liu, N., Wang, H., Zhang, L., & Liu, Z. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkaa763 · Cited by 265
Hu, Y., Chen, J., Hu, G., Yu, J., Zhu, X., Lin, Y., Chen, S., & Yuan, J. (2015) · Marine Drugs · doi:10.3390/md13010202 · Cited by 260
Largazole: From discovery to broad-spectrum therapy
Hong, J., & Luesch, H. (2012) · Natural Product Reports · doi:10.1039/c2np00066k · Cited by 174
Self-citationMarine-Derived Compounds with Potential Use as Cosmeceuticals and Nutricosmetics
Alves, A., Sousa, E., Kijjoa, A., & Pinto, M. (2020) · Molecules · doi:10.3390/molecules25112536 · Cited by 169
Current Status and Future Prospects of Marine Natural Products (MNPs) as Antimicrobials
Choudhary, A., Naughton, L., Montánchez, I., Dobson, A., & Rai, D. (2017) · Marine Drugs · doi:10.3390/md15090272 · Cited by 138
Integrated Metabolomic–Genomic Workflows Accelerate Microbial Natural Product Discovery
Avalon, N. E., Murray, A. E., & Baker, B. J. (2022) · Analytical Chemistry · doi:10.1021/acs.analchem.2c02245 · Cited by 47
Metadata
- Authors
- Montaser, R., & Luesch, H.
- Venue
- Future Medicinal Chemistry
- Publisher
- Informa UK Limited
- Published
- 2011-09
- Volume
- 3
- Issue
- 12
- Pages
- 1475-1489
- ISSN
- 1756-8919 (ISSN-L)
- 1756-8927
- OpenAlex
- W2032889069
- Cited by
- 437
- References
- 88
- FWCI
- 12.77
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.